Osmotica Pharmaceuticals PLC expected to post a loss of 14 cents a share - Earnings Preview

RVL Pharmaceuticals

11/08/2021 03:55

* Osmotica Pharmaceuticals PLC  OSMT.OQ   OSMT.O  is expected
to show a fall in quarterly revenue when it reports results on
August 10 (estimated). 
* The Bridgewater, New Jersey-based company is expected to
report   a 7.9% decrease in revenue to $34.55 million from
$37.53 million a year ago, according to the mean estimate from 2
analysts, based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Osmotica
Pharmaceuticals PLC is for a loss of 14 cents per share. For the
same quarter last year, the company reported a loss of 22 cents
per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Osmotica
Pharmaceuticals PLC is $7​, about 43.6% above​ its last closing
price of $3.95. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.23       -0.23      -0.15     Beat    36.2
 Dec. 31 2020  -0.28       -0.24      -0.88     Missed  -271.8
 Sep. 30 2020  -0.20       -0.20      -0.14     Beat    30​
 Jun. 30 2020  -0.12       -0.12      -0.22     Missed  -76
 Mar.          -0.15​      -0.14      -0.05     Beat    65.1​
 31​ 2020​                                              
 Dec. 31 2019  -0.09       -0.06      -0.51     Missed  -696.9
                                                        ​
 Sep. 30 2019  -0.23       -0.20      -2.15     Missed  -961.7
 Jun. 30 2019  -0.12       -0.14      0.02      Beat    113.8
 This summary was machine generated August 11 at 02:54 GMT.  All
figures in US dollars unless otherwise stated